{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T01:20:35Z","timestamp":1780449635708,"version":"3.54.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,2,28]],"date-time":"2017-02-28T00:00:00Z","timestamp":1488240000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck & Co., Inc.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["ijidonline.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.ijid.2017.02.021","type":"journal-article","created":{"date-parts":[[2017,3,5]],"date-time":"2017-03-05T06:46:47Z","timestamp":1488696407000},"page":"22-26","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Economic Burden of Herpes Zoster (\u201cculebrilla\u201d) in Latin America"],"prefix":"10.1016","volume":"58","author":[{"given":"Emmanouil","family":"Rampakakis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare","family":"Pollock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Vujacich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joao","family":"Toniolo Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Ortiz Covarrubias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Homero","family":"Monsanto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly D.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.ijid.2017.02.021_bib0005","first-page":"1766","article-title":"Herpes zoster","volume":"369","author":"Cohen","year":"2013","journal-title":"N Engl J Med"},{"issue":"16","key":"10.1016\/j.ijid.2017.02.021_bib0010","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1503\/cmaj.091711","article-title":"The impact of herpes zoster and postherpetic neuralgia on health-related quality of life: a prospective study","volume":"182","author":"Drolet","year":"2010","journal-title":"CMAJ"},{"key":"10.1016\/j.ijid.2017.02.021_bib0015","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1741-7015-8-37","article-title":"The impact of herpes zoster and post-herpetic neuralgia on quality-of-life","volume":"8","author":"Johnson","year":"2010","journal-title":"BMC Med"},{"issue":"1","key":"10.1016\/j.ijid.2017.02.021_bib0020","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1017\/S0950268808000678","article-title":"Epidemiology and Cost of Herpes Zoster and Post-Herpetic Neuralgia in the United Kingdom","volume":"137","author":"Gauthier","year":"2009","journal-title":"Epidemiology and Infection"},{"issue":"6","key":"10.1016\/j.ijid.2017.02.021_bib0025","doi-asserted-by":"crossref","first-page":"e004833","DOI":"10.1136\/bmjopen-2014-004833","article-title":"Systematic review of incidence and complications of herpes zoster: towards a global perspective","volume":"4","author":"Kawai","year":"2014","journal-title":"BMJ Open"},{"key":"10.1016\/j.ijid.2017.02.021_bib0030","doi-asserted-by":"crossref","unstructured":"Galil K, Choo PW, Donahue JG, Platt R. The sequelae of herpes zoster. Arch Intern Med. 1997 Jun 9; 157(11):1209-13.","DOI":"10.1001\/archinte.1997.00440320105010"},{"issue":"157","key":"10.1016\/j.ijid.2017.02.021_bib0035","first-page":"571","article-title":"Postherpetic neuralgia","volume":"25","author":"Hope-Simpson","year":"1975","journal-title":"J R Coll Gen Pract"},{"issue":"11","key":"10.1016\/j.ijid.2017.02.021_bib0040","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.4065\/82.11.1341","article-title":"A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction","volume":"82","author":"Yawn","year":"2007","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ijid.2017.02.021_bib0045","unstructured":"CDC. Herpes Zoster Vaccination. Atlanta: National Center for Immunization and Respiratory Diseases; 2015 [cited 2015 10\/23]. Available from: http:\/\/www.cdc.gov\/vaccines\/vpd-vac\/shingles\/hcp-vaccination.htm."},{"issue":"Suppl 2","key":"10.1016\/j.ijid.2017.02.021_bib0050","first-page":"40","article-title":"Epidemiology and burden of herpes zoster and post-herpetic neuralgia in Australia, Asia and South America","volume":"14","author":"Araujo","year":"2007","journal-title":"Herpes"},{"key":"10.1016\/j.ijid.2017.02.021_bib0055","first-page":"129","article-title":"Zoster: mais frequentes entre jovens que entre idosos\/zoster: is more frequent among youngers than aged","volume":"65","author":"Castro","year":"1990","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.ijid.2017.02.021_bib0060","first-page":"287","article-title":"Herpes zoster y cancer: relaciones entre estas dos enfermedades\/herpes zoster and cancer: relationship between these 2 diseases","volume":"6","author":"Gaitan","year":"2008","journal-title":"Acta Med Colomb"},{"issue":"2","key":"10.1016\/j.ijid.2017.02.021_bib0065","first-page":"125","article-title":"Clinical and epidemiological aspects of herpes zoster","volume":"68","author":"Vujacich","year":"2008","journal-title":"Medicina (B Aires)"},{"key":"10.1016\/j.ijid.2017.02.021_bib0070","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ijid.2013.11.018","article-title":"Burden of illness, quality of life, and healthcare utilization among patients with herpes zoster in South Korea: a prospective clinical-epidemiological study","volume":"20","author":"Song","year":"2014","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ijid.2017.02.021_bib0075","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ijid.2015.03.022","article-title":"Predictors of postherpetic neuralgia in patients with herpes zoster: a pooled analysis of prospective cohort studies from North and Latin America and Asia","volume":"34","author":"Kawai","year":"2015","journal-title":"Int J Infect Dis"},{"issue":"6","key":"10.1016\/j.ijid.2017.02.021_bib0080","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jpain.2004.06.001","article-title":"Development of a measure of the burden of pain due to herpes zoster and postherpetic neuralgia for prevention trials: adaptation of the brief pain inventory","volume":"5","author":"Coplan","year":"2004","journal-title":"J Pain"},{"key":"10.1016\/j.ijid.2017.02.021_bib0085","unstructured":"Bolet\u00edn de Estad\u00edsticas Laborales. Ministerio de Trabajo Empleo u Seguridad Social [Internet]. Accessed on: 10\/23\/2015. Available from: http:\/\/www.trabajo.gov.ar\/left\/estadisticas\/bel\/index.asp."},{"key":"10.1016\/j.ijid.2017.02.021_bib0090","unstructured":"Instituto de Opta Medico Asistancial de la Province de Bs. As. (IOMA). Formularios. Buenos Aires 2013 3527\/13."},{"key":"10.1016\/j.ijid.2017.02.021_bib0095","unstructured":"Boletin Oficial de la Ciudad de Buenos Aires:ANEXOS - RESOLUCI\u00d3N N\u00ba 697\/MSGC\/13. Buenos Aires: Gobierno de la Ciudad Autonoma de Buenos Aires IF-2013-02530518."},{"key":"10.1016\/j.ijid.2017.02.021_bib0100","unstructured":"Mexican Institue of Socail Security (IMSS). Mexico city: 2015 406063."},{"key":"10.1016\/j.ijid.2017.02.021_bib0105","unstructured":"Associa\u00e7\u00e3o M\u00e9dica Brasileira (AMB). Classifica\u00e7\u00e3o Brasileira Hierarquizada de Procedimentos M\u00e9dicos. Sao Paulo: 2014 8896619."},{"key":"10.1016\/j.ijid.2017.02.021_bib0110","unstructured":"Listas de Pre\u00e7os de Medicamentos. PRE\u00c7OS M\u00c1XIMOS DE MEDICAMENTOS POR PRINC\u00cdPIO ATIVO: Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria (ANVISA); 2015. p. 918."},{"key":"10.1016\/j.ijid.2017.02.021_bib0115","unstructured":"Inflation calculator and change of price between 2 dates. FXTOP sarl [Internet]. Accessed on: 10\/23\/2015. Available from: http:\/\/fxtop.com\/en\/inflation-calculator.php."},{"key":"10.1016\/j.ijid.2017.02.021_bib0120","doi-asserted-by":"crossref","unstructured":"Morris S. Health Economics For Nurses: Intro Guide: Taylor & Francis; 2014.","DOI":"10.4324\/9781315847450"},{"issue":"1G\u00c7\u00f42","key":"10.1016\/j.ijid.2017.02.021_bib0125","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.pain.2006.09.021","article-title":"Natural history of pain following herpes zoster","volume":"128","author":"Thyregod","year":"2007","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.ijid.2017.02.021_bib0130","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1086\/320884","article-title":"Characteristics of Patients with Herpes Zoster on Presentation to Practitioners in France","volume":"33","author":"Chidiac","year":"2001","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.ijid.2017.02.021_bib0135","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/1471-2334-10-230","article-title":"Epidemiology and economic burden of herpes zoster and post-herpetic neuralgia in Italy: a retrospective, population-based study","volume":"10","author":"Gialloreti","year":"2010","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijid.2017.02.021_bib0140","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/s12889-015-1514-y","article-title":"The humanistic, economic and societal burden of herpes zoster in Europe: a critical review","volume":"15","author":"Gater","year":"2015","journal-title":"BMC Public Health"},{"issue":"6","key":"10.1016\/j.ijid.2017.02.021_bib0145","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1007\/s10198-012-0452-1","article-title":"Epidemiology and cost of herpes zoster and postherpetic neuralgia in Germany","volume":"14","author":"Ultsch","year":"2013","journal-title":"Eur J Health Econ"},{"issue":"49","key":"10.1016\/j.ijid.2017.02.021_bib0150","doi-asserted-by":"crossref","first-page":"8326","DOI":"10.1016\/j.vaccine.2007.09.066","article-title":"Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"25","author":"Pellissier","year":"2007","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.ijid.2017.02.021_bib0155","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.vaccine.2008.11.012","article-title":"Herpes zoster burden of illness and health care resource utilisation in the Australian population aged 50 years and older","volume":"27","author":"Stein","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2017.02.021_bib0160","first-page":"82","article-title":"A population-based study of the incidence and complication rates of herpes zoster before zoster vaccination introduction","author":"Yawn","year":"2007","journal-title":"Mayo Clin Proc"},{"issue":"9","key":"10.1016\/j.ijid.2017.02.021_bib0165","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.vaccine.2005.09.026","article-title":"The burden of Herpes Zoster: a prospective population based study","volume":"24","author":"Scott","year":"2006","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.ijid.2017.02.021_bib0170","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.respe.2010.06.166","article-title":"Burden of herpes zoster and postherpetic neuralgia: Incidence, proportion, and associated costs in the French population aged 50 or over","volume":"58","author":"Mick","year":"2010","journal-title":"Rev Epidemiol Sante Publique"},{"issue":"1","key":"10.1016\/j.ijid.2017.02.021_bib0175","doi-asserted-by":"crossref","first-page":"245","DOI":"10.4161\/hv.36160","article-title":"Evaluation of the economic burden of Herpes Zoster (HZ) infection","volume":"11","author":"Panatto","year":"2015","journal-title":"Hum Vaccin Immunother"},{"issue":"12","key":"10.1016\/j.ijid.2017.02.021_bib0180","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1097\/INF.0b013e31826ff3a5","article-title":"Incidence and use of resources for chickenpox and herpes zoster in Latin America and the Caribbean\u2013a systematic review and meta-analysis","volume":"31","author":"Bardach","year":"2012","journal-title":"Pediatr Infect Dis J"},{"issue":"23-24","key":"10.1016\/j.ijid.2017.02.021_bib0185","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1016\/S0264-410X(01)00044-5","article-title":"The epidemiology of herpes zoster and potential cost-effectiveness of vaccination in England and Wales","volume":"19","author":"Edmunds","year":"2001","journal-title":"Vaccine"},{"issue":"22","key":"10.1016\/j.ijid.2017.02.021_bib0190","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa051016","article-title":"A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"352","author":"Oxman","year":"2005","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.ijid.2017.02.021_bib0195","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2165\/00019053-200725020-00007","article-title":"Acute\/subacute herpes zoster: healthcare resource utilisation and costs in a group of US health plans","volume":"25","author":"Insinga","year":"2007","journal-title":"Pharmacoeconomics"},{"issue":"1","key":"10.1016\/j.ijid.2017.02.021_bib0200","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1017\/S026646230000893X","article-title":"Estimating costs in the economic evaluation of medical technologies","volume":"6","author":"Luce","year":"1990","journal-title":"Int J Technol Assess Health Care"},{"key":"10.1016\/j.ijid.2017.02.021_bib0205","unstructured":"G\u00f3mez Dant\u00e9s O, Sesma S, Becerril VM, Knaul FM, Arreola H, Frenk J. The health system of Mexico. Salud Publica Mex. 2011;53 Suppl 2:s220-32."},{"issue":"9974","key":"10.1016\/j.ijid.2017.02.021_bib0210","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/S0140-6736(14)61646-9","article-title":"Health-system reform and universal health coverage in Latin America","volume":"385","author":"Atun","year":"2015","journal-title":"Lancet"},{"issue":"22","key":"10.1016\/j.ijid.2017.02.021_bib0215","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1056\/NEJMoa1501184","article-title":"Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults","volume":"372","author":"Lal","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2017.02.021_bib0220","doi-asserted-by":"crossref","unstructured":"Doan HQ, Ung B, Ramirez-Fort MK, Khan F, Tyring SK. Zostavax: a subcutaneous vaccine for the prevention of herpes zoster. Expert opinion on biological therapy. 2013;13(10):1467\u201377.","DOI":"10.1517\/14712598.2013.830101"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971217300826?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971217300826?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T09:21:10Z","timestamp":1568884870000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971217300826"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":44,"alternative-id":["S1201971217300826"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2017.02.021","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Economic Burden of Herpes Zoster (\u201cculebrilla\u201d) in Latin America","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2017.02.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Merck Research Labs. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}